247
Participants
Start Date
October 31, 2005
Study Completion Date
July 31, 2006
Armodafinil
Crozer Chester Medical Center, Upland
University of Pennsylvania, Philadelphia
University Services, West Chester
Center for Sleep and Wake Disorders, Chevy Chase
Sleep Disorders Center of the Mid Atlantic, Vienna
Cumberland Research Associates, Fayetteville
SleepMed of South Carolina, Columbia
Child Neurology Associates, PC, Atlanta
Neurotrials, Inc., Atlanta
Sleepmed Inc., Macon
Savannah Neuurology, Savannah
Clinical Research Group of St. Petersburg, St. Petersburg
Sleep Disorders Center of Alabama, Birmingham
Neurology Consultants of Tuscaloosa, P.C., Tuscaloosa
Sleep Medicine of Tennesse, Nashville
Healthstar Physicians, Morristown
Chest Medicine Assocaites d/b/a/ Sleep Medicine Specialists, Louisville
North Coast Clinical Trials, Inc., Beechwood
Neurology and Neuro Science Associates, Akron
Convenant Clinic, Waterloo
Evanston Northwestern Healthcare, Evanston Hospital, Evanston
Neurology and Clinical Study Center, Little Rock
Jonathan Schwartz, Oklahoma City
Metroplex Pulmonary and Sleep Center, PA, Allen
Sleep Medicine Associates of Texas, P.A, Plano
Texas Association of Pediatric Neurology, San Antonio
FutureSearch Trials, Austin
Colorado Sleep Disorder Center, Englewood
Pulmonary Associates, Phoenix
HOPE Research Institute, Phoenix
PsyPharm Clinical Research, Phoenix
PsyPharm Clinical Research Inc., Tucson
Penninsula Research Associates, Rolling Hills Estates
West Coast Clinical Trials, Inc, Long Beach
Neuro-Therapeutics, Inc, Pasadena
Advanced Clinical Research Institute, Anaheim
The Sleep Disorders Center of Santa Barbara, Santa Barbara
Pacific Sleep Program, San Francisco
Pacific Sleep Program, Portland
Pacific Institute of Medical Science, Kirkland
Pacific Institute of Mental Health, Seattle
Neurocare. Inc, Newton
Vermont Medical Sleep Disorders Center, Essex Junction
Lead Sponsor
Cephalon
INDUSTRY